BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

380 related articles for article (PubMed ID: 29136674)

  • 21. Evolution of Our Understanding of the Hyperparathyroid Syndromes: A Historical Perspective.
    Marx SJ; Goltzman D
    J Bone Miner Res; 2019 Jan; 34(1):22-37. PubMed ID: 30536424
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Szalat A; Shpitzen S; Pollack R; Mazeh H; Durst R; Meiner V
    Front Endocrinol (Lausanne); 2023; 14():1254156. PubMed ID: 38130397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sporadic and hereditary primary hyperparathyroidism.
    Pepe J; Cipriani C; Pilotto R; De Lucia F; Castro C; Lenge L; Russo S; Guarnieri V; Scillitani A; Carnevale V; D'Erasmo E; Romagnoli E; Minisola S
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):40-4. PubMed ID: 21985979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CDC73-Related Disorders: Clinical Manifestations and Case Detection in Primary Hyperparathyroidism.
    van der Tuin K; Tops CMJ; Adank MA; Cobben JM; Hamdy NAT; Jongmans MC; Menko FH; van Nesselrooij BPM; Netea-Maier RT; Oosterwijk JC; Valk GD; Wolffenbuttel BHR; Hes FJ; Morreau H
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4534-4540. PubMed ID: 29040582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of familial hyperparathyroidism syndromes: MEN1, MEN2, MEN4, HPT-Jaw tumour, Familial isolated hyperparathyroidism, FHH, and neonatal severe hyperparathyroidism.
    Cristina EV; Alberto F
    Best Pract Res Clin Endocrinol Metab; 2018 Dec; 32(6):861-875. PubMed ID: 30665551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial Hyperparathyroidism.
    Blau JE; Simonds WF
    Front Endocrinol (Lausanne); 2021; 12():623667. PubMed ID: 33716975
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
    Mahajan A; Buse J; Kline G
    Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early-onset, severe, and recurrent primary hyperparathyroidism associated with a novel CDC73 mutation.
    Shibata Y; Yamazaki M; Takei M; Uchino S; Sakurai A; Komatsu M
    Endocr J; 2015; 62(7):627-32. PubMed ID: 25959515
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analyses in patients with familial isolated hyperparathyroidism and hyperparathyroidism-jaw tumour syndrome.
    Mizusawa N; Uchino S; Iwata T; Tsuyuguchi M; Suzuki Y; Mizukoshi T; Yamashita Y; Sakurai A; Suzuki S; Beniko M; Tahara H; Fujisawa M; Kamata N; Fujisawa K; Yashiro T; Nagao D; Golam HM; Sano T; Noguchi S; Yoshimoto K
    Clin Endocrinol (Oxf); 2006 Jul; 65(1):9-16. PubMed ID: 16817812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutation analysis of MEN1, HRPT2, CASR, CDKN1B, and AIP genes in primary hyperparathyroidism patients with features of genetic predisposition.
    Vierimaa O; Villablanca A; Alimov A; Georgitsi M; Raitila A; Vahteristo P; Larsson C; Ruokonen A; Eloranta E; Ebeling TM; Ignatius J; Aaltonen LA; Leisti J; Salmela PI
    J Endocrinol Invest; 2009 Jun; 32(6):512-8. PubMed ID: 19474519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid surgery in familial hyperparathyroid disorders.
    Carling T; Udelsman R
    J Intern Med; 2005 Jan; 257(1):27-37. PubMed ID: 15606374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Germline Mutations Related to Primary Hyperparathyroidism Identified by Next-Generation Sequencing.
    Park HS; Lee YH; Hong N; Won D; Rhee Y
    Front Endocrinol (Lausanne); 2022; 13():853171. PubMed ID: 35586626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of Activating GCM2 Sequence Variants in Sporadic Parathyroid Adenomas.
    Riccardi A; Aspir T; Shen L; Kuo CL; Brown TC; Korah R; Murtha TD; Bellizzi J; Parham K; Carling T; Costa-Guda J; Arnold A
    J Clin Endocrinol Metab; 2019 Jun; 104(6):1948-1952. PubMed ID: 30624640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multilevel Annotation of Germline MEN1 Variants of Synonymous, Nonsynonymous, and Uncertain Significance in Indian Patients With Sporadic Primary Hyperparathyroidism.
    Kaur G; Bhadada SK; Santra M; Pal R; Sarma P; Sachdeva N; Dhiman V; Dahiya D; Saikia UN; Chakraborty A; Sood A; Prakash M; Behera A; Rao SD
    J Bone Miner Res; 2022 Oct; 37(10):1860-1875. PubMed ID: 35856247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium-sensing receptor (CASR) mutations in hypercalcemic states: studies from a single endocrine clinic over three years.
    Guarnieri V; Canaff L; Yun FH; Scillitani A; Battista C; Muscarella LA; Wong BY; Notarangelo A; D'Agruma L; Sacco M; Cole DE; Hendy GN
    J Clin Endocrinol Metab; 2010 Apr; 95(4):1819-29. PubMed ID: 20164288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A contemporary clinical approach to genetic testing for heritable hyperparathyroidism syndromes.
    De Sousa SMC; Carroll RW; Henderson A; Burgess J; Clifton-Bligh RJ
    Endocrine; 2022 Jan; 75(1):23-32. PubMed ID: 34773560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GCM2-Activating Mutations in Familial Isolated Hyperparathyroidism.
    Guan B; Welch JM; Sapp JC; Ling H; Li Y; Johnston JJ; Kebebew E; Biesecker LG; Simonds WF; Marx SJ; Agarwal SK
    Am J Hum Genet; 2016 Nov; 99(5):1034-1044. PubMed ID: 27745835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic testing for hereditary hyperparathyroidism and familial hypocalciuric hypercalcaemia in a large UK cohort.
    Mariathasan S; Andrews KA; Thompson E; Challis BG; Wilcox S; Pierce H; Hale J; Spiden S; Fuller G; Simpson HL; Fish B; Jani P; Seetho I; Armstrong R; Izatt L; Joshi M; Velusamy A; Park SM; Casey RT
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):409-418. PubMed ID: 32430905
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.